Gene · 7472
Papers3,221
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,221
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A single-cell regulatory map of postnatal lung alveologenesis in humans and mice. | Cell Genom | 2022 | 35434692 | PubTator, text mining | PubMed |
| Roles of Wnt/β-catenin signaling pathway related microRNAs in esophageal cancer. | World J Clin Cases | 2022 | 35434118 | PubTator, text mining | PubMed |
| Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells. | Front Oncol | 2022 | 35433479 | PubTator, text mining | PubMed |
| Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC). | Front Oncol | 2022 | 35433461 | PubTator, text mining | PubMed |
| Iron Reduction in Dermacentor andersoni Tick Cells Inhibits Anaplasma marginale Replication. | Int J Mol Sci | 2022 | 35409307 | PubTator, text mining | PubMed |
| Iron Metabolism in Aging and Age-Related Diseases. | Int J Mol Sci | 2022 | 35408967 | PubTator, text mining | PubMed |
| Construction of ceRNA networks with different types of IDH1 mutation status in low-grade glioma patients. | Ann Transl Med | 2022 | 35402587 | PubTator, text mining | PubMed |
| CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies. | Mol Ther Nucleic Acids | 2022 | 35402077 | PubTator, text mining | PubMed |
| Association of has_circ_0001944 upregulations with prognosis and cancer progression in patients with colorectal cancer. | Discov Oncol | 2022 | 35397013 | PubTator, text mining | PubMed |
| Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status. | Front Oncol | 2022 | 35372049 | PubTator, text mining | PubMed |
| Phenotypical, functional and transcriptomic comparison of two modified methods of hepatocyte differentiation from human induced pluripotent stem cells. | Biomed Rep | 2022 | 35371477 | PubTator, text mining | PubMed |
| A Novel Prognostic Model for Identifying the Risk of Hepatocellular Carcinoma Based on Angiogenesis Factors. | Front Genet | 2022 | 35368665 | PubTator, text mining | PubMed |
| Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease. | Front Immunol | 2022 | 35359918 | PubTator, text mining | PubMed |
| Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas. | Front Mol Biosci | 2022 | 35359593 | PubTator, text mining | PubMed |
| Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC. | Front Oncol | 2022 | 35356220 | PubTator, text mining | PubMed |
| mtDNA haplogroup A enhances the effect of obesity on the risk of knee OA in a Mexican population. | Sci Rep | 2022 | 35338224 | PubTator, text mining | PubMed |
| Differences and Interactions in Placental Manganese and Iron Transfer across an In Vitro Model of Human Villous Trophoblasts. | Int J Mol Sci | 2022 | 35328723 | PubTator, text mining | PubMed |
| Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights. | Biomedicines | 2022 | 35327514 | PubTator, text mining | PubMed |
| Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma. | Cancers (Basel) | 2022 | 35326741 | PubTator, text mining | PubMed |
| Iron Regulatory Protein 1 Inhibits Ferritin Translation Responding to OsHV-1 Infection in Ark Clams, Scapharca Broughtonii. | Cells | 2022 | 35326435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7472/papers?page=38